Podcast Episodes
Back to Search
Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen
How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing? Listen thi…
8 years, 4 months ago
Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes
What do you call a unicorn without a horn? Is your colleague wearing a wire? And is Jentadueto a drug name or a complicated espresso drink?
8 years, 5 months ago
Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?
On today's show, we dig into the no good, very bad day Novartis had when the world got wind of its ties to President Trump's personal attorney, a dis…
8 years, 5 months ago
Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics
We talk to Bill Gates about the flu that could kill millions. Is China too enamored with biotech startups? And how do you find a cold case killer? Ge…
8 years, 5 months ago
Episode #8 - Megamergers, migraines, and biotech's Four Horsemen
What's a good use of $64 billion? Is Big Biotech boring now? And what's the best way to sell hair restoration products to men?
8 years, 5 months ago
Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism
Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?
8 years, 5 months ago
Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR
Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged…
8 years, 6 months ago
Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr
What's it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?
8 years, 6 months ago
Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card
Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book f…
8 years, 6 months ago
Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?
What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?
8 years, 6 months ago